Lemaitre Vascular LMAT
NASDAQ LMAT
$78.74 -0.73 (-0.92%)
As of: Sep 10, 2026 · 3:59 PM EDT

Lemaitre Vascular (LMAT) Other Non-Current Liabilities (2010 - 2026)

Lemaitre Vascular's (LMAT) quarterly Other Non-Current Liabilities came in at $1.5 million in Q2 2026, up 56.21% year-over-year from $934000.0 in Q2 2025, and up 11.29% quarter-over-quarter from $1.3 million in Q1 2026.

Analysis

Lemaitre Vascular (LMAT) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends

Lemaitre Vascular (LMAT) has reported Other Non-Current Liabilities for 17 consecutive years, with $1.5 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Other Non-Current Liabilities rose 56.21% year-over-year to $1.5 million in Q2 2026; TTM through Jun 2026 was $1.5 million, a 56.21% increase from a year earlier, with the FY2025 full-year figure at $1.5 million, up 76.65% from the prior year.
  • Other Non-Current Liabilities was $1.5 million for Q2 2026 at Lemaitre Vascular, up from $1.3 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $2.6 million in Q1 2022 and troughed at $831000.0 in Q4 2024.
  • A 5-year average of $1.8 million and a median of $2.2 million in 2022 frame the typical range for Other Non-Current Liabilities.
  • Across the five-year window, Other Non-Current Liabilities slumped 63.36% in 2024 and jumped 76.65% in 2025, its largest moves.
  • Over 5 years, Other Non-Current Liabilities stood at $2.2 million in 2022, then climbed by 4.66% to $2.3 million in 2023, then tumbled by 63.36% to $831000.0 in 2024, then jumped by 76.65% to $1.5 million in 2025, then dropped by 0.61% to $1.5 million in 2026.
  • The last three Other Non-Current Liabilities figures came in at $1.5 million (Q2 2026), $1.3 million (Q1 2026), and $1.5 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn
10 Lemaitre Vascular 1.80 Bn 1.43 Bn 50.76 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.46 Mn
Mar 31, 2026 1.31 Mn
Dec 31, 2025 1.47 Mn
Sep 30, 2025 933,000.00
Jun 30, 2025 934,000.00
Mar 31, 2025 875,000.00
Dec 31, 2024 831,000.00
Sep 30, 2024 896,000.00
Jun 30, 2024 2.18 Mn
Mar 31, 2024 2.18 Mn
Dec 31, 2023 2.27 Mn
Sep 30, 2023 2.15 Mn
Jun 30, 2023 2.26 Mn
Mar 31, 2023 2.28 Mn
Dec 31, 2022 2.17 Mn
Sep 30, 2022 2.41 Mn
Jun 30, 2022 2.50 Mn
Mar 31, 2022 2.63 Mn
Dec 31, 2021 2.70 Mn
Sep 30, 2021 3.60 Mn